Isis Pharmaceuticals: What is the sense in antisense?

Expert Opinion on Therapeutic Patents

Volumn 7, Issue 8, 1997, Pages 813-819

  Thomas, S M ^a   Burke, J F ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALICAFORSEN; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; ANTIVIRUS AGENT; CGP 69846A; FOMIVIRSEN; GENE EXPRESSION MODULATOR 132; ISIS 2503; ISIS 3521; LR 3280; PROTEIN KINASE C; UNCLASSIFIED DRUG; ZINTEVIR;

CANCER; CLINICAL TRIAL; DRUG DEVELOPMENT; DRUG SYNTHESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; PATENT; SHORT SURVEY;

EID: 0030855013     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.7.8.813     Document Type: Short Survey

References (3)